Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial

(1999) · The Lancet · doi:10.1016/s0140-6736(99)07072-5 · Cited by 3,812 · see citing works

Pro-resolving lipid mediators are leads for resolution physiology

Serhan, C. N. (2014) · Nature · doi:10.1038/nature13479 · Cited by 3,041 · see citing works

n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases

Calder, P. C. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1505s · Cited by 2,525 · see citing works

Untitled work

(1999) · PubMed · Cited by 2,062 · see citing works

The Human Serum Metabolome

Psychogios, N., Hau, D., Peng, J., Guo, A. C., Mandal, R., Bouatra, S., Sinelnikov, I. V., Krishnamurthy, R., Eisner, R., Gautam, B., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016957 · Cited by 1,718 · see citing works

Robbins and Cotran Pathologic Basis of Disease

Hoda, S. A., & Hoda, R. S. (2005) · Advances in Anatomic Pathology · doi:10.1097/01.pap.0000155072.86944.7d · Cited by 1,578 · see citing works

Lipid mediator class switching during acute inflammation: signals in resolution

Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453 · see citing works

Distribution, interconversion, and dose response of n-3 fatty acids in humans.

Arterburn, L. M., Hall, E. B., & Oken, H. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1467s · Cited by 1,162 · see citing works

Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities

Tabas, I., & Glass, C. K. (2013) · Science · doi:10.1126/science.1230720 · Cited by 1,093 · see citing works

n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia

The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203859 · Cited by 929 · see citing works

Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease

Haeggström, J. Z., & Funk, C. D. (2011) · Chemical Reviews · doi:10.1021/cr200246d · Cited by 875 · see citing works

The Effect of Polyphenols in Olive Oil on Heart Disease Risk Factors: A Randomized Trial

Covas, M.-I., Nyyssönen, K., Poulsen, H. E., Kaikkonen, J., Zunft, H.-J. F., Kiesewetter, H., Gaddi, A., de la Torre, R., Mursu, J., Bäumler, H., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-5-200609050-00006 · Cited by 758 · see citing works

n–3 Fatty Acids in Cardiovascular Disease

Caterina, R. D. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1008153 · Cited by 568 · see citing works

Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators

Dalli, J., & Serhan, C. N. (2012) · Blood · doi:10.1182/blood-2012-04-423525 · Cited by 556 · see citing works

Inflammation and its Resolution as Determinants of Acute Coronary Syndromes

Libby, P., Tabas, I. A., Fredman, G., & Fisher, E. A. A. (2014) · Circulation Research · doi:10.1161/circresaha.114.302699 · Cited by 523 · see citing works

Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue

Colas, R. A., Shinohara, M., Dalli, J., Chiang, N., & Serhan, C. N. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00024.2014 · Cited by 424 · see citing works

Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators

Merched, A. J., Ko, K., Gotlinger, K. H., Serhan, C. N., & Chan, L. (2008) · The FASEB Journal · doi:10.1096/fj.08-112201 · Cited by 414 · see citing works

Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway

Karp, C. L., Flick, L. M., Park, K. W., Softic, S., Greer, T. M., Keledjian, R., Yang, R., Uddin, J., Guggino, W. B., Atabani, S. F., et al. (2004) · Nature Immunology · doi:10.1038/ni1056 · Cited by 344 · see citing works

Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: A potentially protective mechanism in atherosclerotic vascular disease and cancer

Scoditti, E., Calabriso, N., Massaro, M., Pellegrino, M., Storelli, C., Martines, G., Caterina, R. D., & Carluccio, M. A. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.05.003 · Cited by 323 · see citing works

Safety and Efficacy of Omacor in Severe Hypertriglyceridemia

Harris, W. S., Ginsberg, H. N., Arunakul, N., Shachter, N. S., Windsor, S. L., Adams, M., Berglund, L., & Osmundsen, K. (1997) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679700400511 · Cited by 306 · see citing works

Plasma Phospholipid Long-Chain ω-3 Fatty Acids and Total and Cause-Specific Mortality in Older Adults: A Cohort Study

Mozaffarian, D., Lemaitre, R. N., King, I. B., Song, X., Huang, H., Sacks, F. M., Rimm, E. B., Wang, M., & Siscovick, D. S. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-7-201304020-00003 · Cited by 283 · see citing works

Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation

Mas, E., Croft, K. D., Zahra, P., Barden, A., & Mori, T. A. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.190199 · Cited by 270 · see citing works

Aspirin triggers antiinflammatory 15-epi-lipoxin A 4 and inhibits thromboxane in a randomized human trial

Chiang, N., Bermudez, E. A., Ridker, P. M., Hurwitz, S., & Serhan, C. N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405445101 · Cited by 266 · see citing works

Effects of Olive Oil on Markers of Inflammation and Endothelial Function—A Systematic Review and Meta-Analysis

Schwingshackl, L., Christoph, M., & Hoffmann, G. (2015) · Nutrients · doi:10.3390/nu7095356 · Cited by 252 · see citing works

Safety and efficacy of Omacor in severe hypertriglyceridemia

Harris, W. S., Ginsberg, H. N., Arunakul, N., Shachter, N. S., Windsor, S. L., Adams, M., Berglund, L., & Osmundsen, K. (1997) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199710000-00011 · Cited by 252 · see citing works

Diminished Lipoxin Biosynthesis in Severe Asthma

Levy, B. D., Bonnans, C., Silverman, E. S., Palmer, L. J., Marigowda, G., & Israel, E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200410-1413oc · Cited by 250 · see citing works

Rapid Appearance of Resolvin Precursors in Inflammatory Exudates: Novel Mechanisms in Resolution

Kasuga, K., Yang, R., Porter, T. F., Agrawal, N., Petasis, N. A., Irimia, D., Toner, M., & Serhan, C. N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8677 · Cited by 240 · see citing works

Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function

Kain, V., Ingle, K. A., Colas, R. A., Dalli, J., Prabhu, S. D., Serhan, C. N., Joshi, M. D., & Halade, G. V. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.04.003 · Cited by 234 · see citing works

Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets

Dona, M., Fredman, G., Schwab, J. M., Chiang, N., Arita, M., Goodarzi, A., Cheng, G., von Andrian, U. H., & Serhan, C. N. (2008) · Blood · doi:10.1182/blood-2007-11-122598 · Cited by 228 · see citing works

Aspirin-Triggered Lipoxin and Resolvin E1 Modulate Vascular Smooth Muscle Phenotype and Correlate with Peripheral Atherosclerosis

Ho, K. J., Spite, M., Owens, C. D., Lancero, H., Kroemer, A. H. K., Pande, R., Creager, M. A., Serhan, C. N., & Conte, M. S. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.091082 · Cited by 204 · see citing works

Resolvin E1 (RvE1) Attenuates Atherosclerotic Plaque Formation in Diet and Inflammation-Induced Atherogenesis

Hasturk, H., Abdallah, R., Kantarci, A., Nguyen, D., Giordano, N., Hamilton, J., & Van Dyke, T. E. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.115.305324 · Cited by 199 · see citing works

Omega-3 Polyunsaturated Fatty Acids and the Treatment of Rheumatoid Arthritis: A Meta-analysis

Lee, Y. H., Bae, S., & Song, G. G. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.06.011 · Cited by 197 · see citing works

Circulating and Dietary Omega‐3 and Omega‐6 Polyunsaturated Fatty Acids and Incidence of CVD in the Multi‐Ethnic Study of Atherosclerosis

Otto, M. C. D. O., Wu, J. H. Y., Baylín, A., Vaidya, D. M., Rich, S. S., Tsai, M. Y., Jacobs, D. R., & Mozaffarian, D. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000506 · Cited by 178 · see citing works

Augmentation of Myocardial Production of 15-Epi-Lipoxin-A 4 by Pioglitazone and Atorvastatin in the Rat

Birnbaum, Y., Ye, Y., Lin, Y., Freeberg, S. Y., Nishi, S. P. E., Martinez, J. D., Huang, M.-H., Uretsky, B. F., & Perez-Polo, J. R. (2006) · Circulation · doi:10.1161/circulationaha.106.629907 · Cited by 173 · see citing works

Role of Basic Science in the Development of New Medicines: Examples from the Eicosanoid Field

Samuelsson, B. O. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.x112.351437 · Cited by 157 · see citing works

Impaired Phagocytosis in Localized Aggressive Periodontitis: Rescue by Resolvin E1

Fredman, G., Oh, S. F., Ayilavarapu, S., Hastürk, H., Serhan, C. N., & Dyke, T. E. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024422 · Cited by 154 · see citing works

Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, double blind, placebo controlled trials

Casula, M., Soranna, D., Catapano, A. L., & Corrao, G. (2013) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(13)70005-9 · Cited by 152 · see citing works

D‐series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury

Miyahara, T., Runge, S. J., Chatterjee, A., Chen, M., Mottola, G., Fitzgerald, J. M., Serhan, C. N., & Conte, M. S. (2013) · The FASEB Journal · doi:10.1096/fj.12-225615 · Cited by 134 · see citing works

Resolvin E1 Metabolome in Local Inactivation during Inflammation-Resolution

Hong, S., Porter, T. F., Lu, Y., Oh, S. F., Pillai, P. S., & Serhan, C. N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3512 · Cited by 107 · see citing works

Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis.

Cleland, L. G., Caughey, G. E., James, M. J., & Proudman, S. (2006) · PubMed · Cited by 105 · see citing works

Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice

Akagi, D., Chen, M., Toy, R., Chatterjee, A., & Conte, M. (2015) · The FASEB Journal · doi:10.1096/fj.14-265363 · Cited by 104 · see citing works

The Pro-Resolving Lipid Mediator Maresin 1 (MaR1) Attenuates Inflammatory Signaling Pathways in Vascular Smooth Muscle and Endothelial Cells

Chatterjee, A., Sharma, A., Chen, M., Toy, R., Mottola, G., & Conte, M. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113480 · Cited by 90 · see citing works

Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammation

Barden, A. E., Mas, E., Croft, K. D., Phillips, M. R., & Mori, T. A. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m045583 · Cited by 86 · see citing works

Impact of omega-3 polyunsaturated fatty acids on coronary plaque instability: An integrated backscatter intravascular ultrasound study

Amano, T., Matsubara, T., Uetani, T., Kato, M., Kato, B., Yoshida, T., Harada, K., Kumagai, S., Kunimura, A., Shinbo, Y., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.05.030 · Cited by 83 · see citing works

New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases

Yacoubian, S., & Serhan, C. N. (2007) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0616 · Cited by 80 · see citing works

n-3 Fatty acid supplementation and proresolving mediators of inflammation

Barden, A. E., Mas, E., & Mori, T. A. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000262 · Cited by 77 · see citing works

Determination of ω-6 and ω-3 PUFA metabolites in human urine samples using UPLC/MS/MS

Sasaki, A., Fukuda, H., Shiida, N., Tanaka, N. K., Furugen, A., Ogura, J., Shuto, S., Mano, N., & Yamaguchi, H. (2015) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-8412-5 · Cited by 58 · see citing works

Dietary n-3 fats as adjunctive therapy in a prototypic inflammatory disease: issues and obstacles for use in rheumatoid arthritis

James, M. J., Proudman, S., & Cleland, L. G. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(03)00064-4 · Cited by 55 · see citing works

A near null variant of 12/15-LOX encoded by a novel SNP in ALOX15 and the risk of coronary artery disease

Assimes, T. L., Knowles, J. W., Priest, J. R., Basu, A., Borchert, A., Volcik, K. A., Grove, M. L., Tabor, H. K., Southwick, A. M., Tabibiazar, R., et al. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.09.003 · Cited by 49 · see citing works

Intravenous application of omega‐3 fatty acids in patients with active rheumatoid arthritis. The ORA‐1 trial. An open pilot study

Leeb, B. F., Sautner, J., Andel, I., & Rintelen, B. (2006) · Lipids · doi:10.1007/11745-006-5066-x · Cited by 41 · see citing works

The c.–292C>T promoter polymorphism increases reticulocyte-type 15-lipoxygenase-1 activity and could be atheroprotective

Wittwer, J., Bayer, M., Mosandl, A., Muntwyler, J., & Hersberger, M. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.103 · Cited by 39 · see citing works

Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators

Serhan, C. N., & Levy, B. D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97943 · Cited by 1,344 · see citing works

Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities

Bäck, M., Yurdagul, A., Tabas, I., Öörni, K., & Kovanen, P. T. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0169-2 · Cited by 1,341 · see citing works

Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms

Serhan, C. N. (2017) · The FASEB Journal · doi:10.1096/fj.201601222r · Cited by 553 · see citing works

An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques

Fredman, G., Hellmann, J., Proto, J. D., Kuriakose, G., Colas, R. A., Dorweiler, B., Connolly, E. S., Solomon, R., Jones, D. M., Heyer, E. J., et al. (2016) · Nature Communications · doi:10.1038/ncomms12859 · Cited by 411 · see citing works

Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors

Chiang, N., & Serhan, C. N. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.03.005 · Cited by 330 · see citing works

Mechanisms and Consequences of Defective Efferocytosis in Atherosclerosis

Yurdagul, A., Doran, A. C., Cai, B., Fredman, G., & Tabas, I. A. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00086 · Cited by 300 · see citing works

Resolvins suppress tumor growth and enhance cancer therapy

Sulciner, M. L., Serhan, C. N., Gilligan, M. M., Mudge, D. K., Chang, J., Gartung, A., Lehner, K. A., Bielenberg, D. R., Schmidt, B. A. R., Dalli, J., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20170681 · Cited by 259 · see citing works

Arachidonic acid and other unsaturated fatty acids and some of their metabolites function as endogenous antimicrobial molecules: A review

Das, U. N. (2018) · Journal of Advanced Research · doi:10.1016/j.jare.2018.01.001 · Cited by 256 · see citing works

New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration

Serhan, C. N., Chiang, N., & Dalli, J. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.08.002 · Cited by 246 · see citing works

Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology

Sansbury, B. E., & Spite, M. R. (2016) · Circulation Research · doi:10.1161/circresaha.116.307308 · Cited by 226 · see citing works

Macrophage Trafficking, Inflammatory Resolution, and Genomics in Atherosclerosis

Moore, K. J., Koplev, S., Fisher, E. A. A., Tabas, I. A., Björkegren, J., Doran, A. C., & Kovacic, J. C. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.08.2147 · Cited by 221 · see citing works

Inflammation and resolution in obesity

Soták, M., Clark, M., Suur, B. E., & Börgeson, E. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01047-y · Cited by 234 · see citing works

Carcinogenesis: Failure of resolution of inflammation?

Fishbein, A., Hammock, B. D., Serhan, C. N., & Panigrahy, D. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107670 · Cited by 207 · see citing works

The role of efferocytosis‐fueled macrophage metabolism in the resolution of inflammation

Schilperoort, M., Ngai, D., Sukka, S. R., Avrampou, K., Shi, H., & Tabas, I. A. (2023) · Immunological Reviews · doi:10.1111/imr.13214 · Cited by 181 · see citing works

Boosting Inflammation Resolution in Atherosclerosis

Fredman, G., & Tabas, I. A. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.01.018 · Cited by 173 · see citing works

Inflammation Resolution: Implications for Atherosclerosis

Doran, A. C. (2022) · Circulation Research · doi:10.1161/circresaha.121.319822 · Cited by 177 · see citing works

Dietary fats and cardiometabolic disease: mechanisms and effects on risk factors and outcomes

Wu, J. H. Y., Micha, R., & Mozaffarian, D. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0206-1 · Cited by 167 · see citing works

Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular disease

Fredman, G., & Serhan, C. N. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00984-x · Cited by 160 · see citing works

Eicosapentaenoic and docosahexaenoic acid derived specialised pro-resolving mediators: Concentrations in humans and the effects of age, sex, disease and increased omega-3 fatty acid intake

Calder, P. C. (2020) · Biochimie · doi:10.1016/j.biochi.2020.08.015 · Cited by 145 · see citing works

Polyunsaturated Fatty Acids: Conversion to Lipid Mediators, Roles in Inflammatory Diseases and Dietary Sources

Harwood, J. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108838 · Cited by 144 · see citing works

Δ-5 Fatty Acid Desaturase <i>FADS1</i> Impacts Metabolic Disease by Balancing Proinflammatory and Proresolving Lipid Mediators

Gromovsky, A. D., Schugar, R. C., Brown, A. L., Helsley, R. N., Burrows, A. C., Ferguson, D., Zhang, R., Sansbury, B. E., Lee, R. G., Morton, R. E., et al. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.117.309660 · Cited by 115 · see citing works

Narrative Review of n-3 Polyunsaturated Fatty Acid Supplementation upon Immune Functions, Resolution Molecules and Lipid Peroxidation

Zaloga, G. P. (2021) · Nutrients · doi:10.3390/nu13020662 · Cited by 106 · see citing works

Specialized pro-resolving mediators in cardiovascular diseases

Fredman, G., & Spite, M. R. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.02.003 · Cited by 98 · see citing works

Resolvin D4 attenuates the severity of pathological thrombosis in mice

Cherpokova, D., Jouvene, C. C., Libreros, S., DeRoo, E., Chu, L., de la Rosa, X., Norris, P. C., Wagner, D. D., & Serhan, C. N. (2019) · Blood · doi:10.1182/blood.2018886317 · Cited by 97 · see citing works

Effect of Eicosapentaenoic and Docosahexaenoic Acids Added to Statin Therapy on Coronary Artery Plaque in Patients With Coronary Artery Disease: A Randomized Clinical Trial

Alfaddagh, A., Elajami, T. K., Ashfaque, H., Saleh, M. A., Bistrian, B. R., & Welty, F. K. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006981 · Cited by 95 · see citing works

Targeting immune cell recruitment in atherosclerosis

Döring, Y., van der Vorst, E. P. C., & Weber, C. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01023-z · Cited by 90 · see citing works

The resolution of inflammation through omega-3 fatty acids in atherosclerosis, intimal hyperplasia, and vascular calcification

Carracedo, M., Artiach, G., Arnardottir, H. H., & Bäck, M. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00767-y · Cited by 92 · see citing works

Pro-resolving lipid mediators in vascular disease

Conte, M. S., Desai, T. A., Wu, B., Schaller, M. S., & Werlin, E. C. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97947 · Cited by 81 · see citing works

Specialized pro-resolving lipid mediators: A new class of non-immunosuppressive and non-opioid analgesic drugs

Fattori, V., Zaninelli, T. H., Rasquel-Oliveira, F. S., Casagrande, R., & Verri, W. A., Jr. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104549 · Cited by 80 · see citing works

Pneumonia-Induced Inflammation, Resolution and Cardiovascular Disease: Causes, Consequences and Clinical Opportunities

Stotts, C., Corrales‐Medina, V., & Rayner, K. J. (2023) · Circulation Research · doi:10.1161/circresaha.122.321636 · Cited by 86 · see citing works

Stimulating the Resolution of Inflammation Through Omega-3 Polyunsaturated Fatty Acids in COVID-19: Rationale for the COVID-Omega-F Trial

Arnardottir, H. H., Pawelzik, S., Öhlund‐Wistbacka, U., Artiach, G., Hofmann, R., Reinholdsson, I., Braunschweig, F., Tornvall, P., Religa, D., & Bäck, M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.624657 · Cited by 75 · see citing works

A cluster of immunoresolvents links coagulation to innate host defense in human blood

Norris, P. C., Libreros, S., Chiang, N., & Serhan, C. N. (2017) · Science Signaling · doi:10.1126/scisignal.aan1471 · Cited by 68 · see citing works

Omega-3 Fatty Acids in Atherosclerosis and Coronary Artery Disease

Bäck, M. (2017) · Future Science OA · doi:10.4155/fsoa-2017-0067 · Cited by 69 · see citing works

Omega 3 Fatty Acid and Skin Diseases

Sawada, Y., Saito‐Sasaki, N., & Nakamura, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.623052 · Cited by 68 · see citing works

Chronic Inflammation in PCOS: The Potential Benefits of Specialized Pro-Resolving Lipid Mediators (SPMs) in the Improvement of the Resolutive Response

Regidor, P., Mueller, A., Sailer, M., Santos, F. G., Rizo, J. M., & Egea, F. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010384 · Cited by 69 · see citing works

The great obstetrical syndromes and the placenta

Hoffman, M. (2023) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17613 · Cited by 67 · see citing works

Resolution of vascular injury: Specialized lipid mediators and their evolving therapeutic implications

Wu, B., Mottola, G., Schaller, M. S., Upchurch, G. R., & Conte, M. S. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.07.005 · Cited by 64 · see citing works

Fish Oil Increases Specialized Pro-resolving Lipid Mediators in PAD (The OMEGA-PAD II Trial)

Ramirez, J. L., Gasper, W. J., Khetani, S. A., Zahner, G. J., Hills, N. K., Mitchell, P. T., Sansbury, B. E., Conte, M. S., Spite, M. R., & Grenon, S. M. (2019) · Journal of Surgical Research · doi:10.1016/j.jss.2019.01.038 · Cited by 62 · see citing works

Regression of human coronary artery plaque is associated with a high ratio of (18‐hydroxy‐eicosapentaenoic acid + resolvin E1) to leukotriene B 4

Welty, F. K., Schulte, F., Alfaddagh, A., Elajami, T. K., Bistrian, B. R., & Hardt, M. (2021) · The FASEB Journal · doi:10.1096/fj.202002471r · Cited by 57 · see citing works

Atherosclerosis, Periodontal Disease, and Treatment with Resolvins

Hamilton, J. A., Hastürk, H., Kantarcı, A., Serhan, C. N., & Dyke, T. E. V. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0696-4 · Cited by 54 · see citing works

Aspirin for the Primary Prevention of Cardiovascular Disease: Time for a Platelet-Guided Approach

Cofer, L. B., Barrett, T. J., & Berger, J. S. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.318020 · Cited by 52 · see citing works

Insights into the cardioprotective properties of n-3 PUFAs against ischemic heart disease via modulation of the innate immune system

Darwesh, A. M., Sosnowski, D. K., Lee, T. Y., Keshavarz-Bahaghighat, H., & Seubert, J. M. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.04.037 · Cited by 49 · see citing works

Effects of Aspirin on Endothelial Function and Hypertension

Dzeshka, M. S., Shantsila, A., & Lip, G. Y. H. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0688-8 · Cited by 47 · see citing works

The Role of Resolvins: EPA and DHA Derivatives Can Be Useful in the Prevention and Treatment of Ischemic Stroke

Tułowiecka, N., Kotlęga, D., Prowans, P., & Szczuko, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207628 · Cited by 45 · see citing works

Resolvin D2 Attenuates Cardiovascular Damage in Angiotensin II-Induced Hypertension

del Campo, L. S. D., García‐Redondo, A. B., Rodrı́guez, C., Zaragoza, C., Duro‐Sánchez, S., Palmas, F., de Benito-Bueno, Á., Socuéllamos, P. G., Peraza, D. A., Rodrigues‐Díez, R., et al. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19448 · Cited by 44 · see citing works

Modulation of innate immunity of patients with Alzheimer's disease by omega‐3 fatty acids

Fiala, M., Kooij, G., Wagner, K. M., Hammock, B. D., & Pellegrini, M. A. (2017) · The FASEB Journal · doi:10.1096/fj.201700065r · Cited by 44 · see citing works

Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases

Perucci, L. O., Sugimoto, M. A., Gomes, K. B., Dusse, L. M. S., Teixeira, M. M., & Sousa, L. P. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1364363 · Cited by 45 · see citing works

Lipoxin B4 Enhances Human Memory B Cell Antibody Production via Upregulating Cyclooxygenase-2 Expression

Kim, N., Lannan, K. L., Thatcher, T. H., Pollock, S. J., Woeller, C. F., & Phipps, R. P. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700503 · Cited by 42 · see citing works

Polyunsaturated fatty acids, specialized pro-resolving mediators, and targeting inflammation resolution in the age of precision nutrition

Al‐Shaer, A. E., Buddenbaum, N., & Shaikh, S. R. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.158936 · Cited by 44 · see citing works

Resolvins as proresolving inflammatory mediators in cardiovascular disease

Capó, X., Martorell, M., Busquets-Cortés, C., Tejada, S., Tur, J. A., Pons, A., & Sureda, A. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.07.018 · Cited by 42 · see citing works

Early increase of specialized pro-resolving lipid mediators in patients with ST-elevation myocardial infarction

Fosshaug, L. E., Colas, R. A., Anstensrud, A. K., Gregersen, I., Nymo, S. H., Sagen, E. L., Michelsen, A. E., Vinge, L. E., Øie, E., Gullestad, L. L., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.07.024 · Cited by 42 · see citing works

Novel RvD6 stereoisomer induces corneal nerve regeneration and wound healing post-injury by modulating trigeminal transcriptomic signature

Pham, T. L., Kakazu, A. H., He, J., Jun, B., Bazan, N. G., & Bazán, H. E. P. (2020) · Scientific Reports · doi:10.1038/s41598-020-61390-8 · Cited by 42 · see citing works

Roles of Resolvins in Chronic Inflammatory Response

Liu, C., Fan, D., Lei, Q., Lü, A., & He, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314883 · Cited by 41 · see citing works

Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway

Mottola, G., Chatterjee, A., Wu, B., Chen, M., & Conte, M. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174936 · Cited by 41 · see citing works

Omega‐3 fatty acids in coronary heart disease: Recent updates and future perspectives

Ajith, T. A., & Jayakumar, T. G. (2018) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13034 · Cited by 41 · see citing works

Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes

Sima, C., Paster, B. J., & Dyke, T. E. V. (2018) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2018026750 · Cited by 39 · see citing works

Specialized pro-resolving lipid mediators in cardiovascular disease, diagnosis, and therapy

Kim, A. S., & Conte, M. S. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.011 · Cited by 40 · see citing works

Early evidence of efficacy for orally administered SPM-enriched marine lipid fraction on quality of life and pain in a sample of adults with chronic pain

Callan, N. G. L., Hanes, D., & Bradley, R. D. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02569-5 · Cited by 40 · see citing works

Atherothrombosis and the NLRP3 inflammasome – endogenous mechanisms of inhibition

Satish, M., & Agrawal, D. K. (2019) · Translational research · doi:10.1016/j.trsl.2019.08.003 · Cited by 37 · see citing works

The effect of polyunsaturated fatty acids on the severity and mortality of COVID patients: A systematic review

Mazidimoradi, A., Alemzadeh, E., Alemzadeh, E., & Salehiniya, H. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120489 · Cited by 37 · see citing works

Aspirin Triggered Resolvin D1 reduces inflammation and restores saliva secretion in a Sjögren’s syndrome mouse model

Dean, S. M., Wang, C., Nam, K., Maruyama, C. L., Trump, B., & Baker, O. J. (2019) · Lara D. Veeken · doi:10.1093/rheumatology/kez072 · Cited by 36 · see citing works

Icosapent ethyl in cardiovascular prevention: Resolution of inflammation through the eicosapentaenoic acid - resolvin E1 - ChemR23 axis

Bäck, M. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108439 · Cited by 34 · see citing works

Specialized pro‐resolving mediators enhance the clearance of dead cells

Fredman, G., & Khan, S. (2023) · Immunological Reviews · doi:10.1111/imr.13278 · Cited by 34 · see citing works

Deep Airway Inflammation and Respiratory Disorders in Nanocomposite Workers

Pelclová, D., Ždı́mal, V., Komarc, M., Vlčková, Š., Fenclová, Z., Ondráček, J., Schwarz, J., Koštejn, M., Kačer, P., Dvorackova, S., et al. (2018) · Nanomaterials · doi:10.3390/nano8090731 · Cited by 34 · see citing works

Specialized Pro-Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling

del Campo, L. S. D., Rodrigues‐Díez, R., Salaíces, M., Briones, A. M., & García‐Redondo, A. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073592 · Cited by 33 · see citing works

Pro resolving inflammatory effects of the lipid mediators of omega 3 fatty acids and its implication in SARS COVID-19

Regidor, P., Santos, F. G., Rizo, J. M., & Egea, F. M. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110340 · Cited by 33 · see citing works

Immunomodulation by intravenous omega‐3 fatty acid treatment in older subjects hospitalized for COVID‐19: A single‐blind randomized controlled trial

Arnardottir, H. H., Pawelzik, S., Sarajlic, P., Quaranta, A., Kolmert, J., Religa, D., Wheelock, C. E., & Bäck, M. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.895 · Cited by 33 · see citing works

Variability in the Clinical Effects of the Omega-3 Polyunsaturated Fatty Acids DHA and EPA in Cardiovascular Disease—Possible Causes and Future Considerations

Michaeloudes, C., Christodoulides, S., Christodoulou, P., Kyriakou, T.-C., Patrikios, I. S., & Stephanou, A. (2023) · Nutrients · doi:10.3390/nu15224830 · Cited by 32 · see citing works

Pro-Resolving Ligands Orchestrate Phagocytosis

Decker, C., Sadhu, S., & Fredman, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.660865 · Cited by 30 · see citing works

Classes of Lipid Mediators and Their Effects on Vascular Inflammation in Atherosclerosis

Lubrano, V., Ndreu, R., & Balzan, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021637 · Cited by 30 · see citing works

Specialized Pro-Resolving Mediators as Potential Regulators of Inflammatory Macrophage Responses in COVID-19

Balta, M. G., Papathanasiou, E., & CHRISTOPOULOS, P. F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.632238 · Cited by 28 · see citing works

Lipoxins modulate neutrophil oxidative burst, integrin expression and lymphatic transmigration differentially in human health and atherosclerosis

Kraft, J. D., Blomgran, R., Bergström, I., Soták, M., Clark, M., Rani, A., Rajan, M. R., Dalli, J., Nyström, S., Quiding‐Järbrink, M., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202101219rr · Cited by 29 · see citing works

Rapid Metabolization of Protectin D1 by β-Oxidation of Its Polar Head Chain

Balas, L., Risé, P., Dayaker, G., Rovati, G. E., Bolego, C., Stellari, F. F., Trenti, A., Buccellati, C., Durand, T., & Sala, A. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01463 · Cited by 27 · see citing works

Dietary Control of Inflammation and Resolution

Sears, B., & Saha, A. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.709435 · Cited by 22 · see citing works

Specialized pro-resolving mediators in diabetes: novel therapeutic strategies

Brennan, E. P., Mohan, M., Andrews, D. C., Bose, M., & Kantharidis, P. (2019) · Clinical Science · doi:10.1042/cs20190067 · Cited by 27 · see citing works

Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis

Salazar, J. J., Pírela, D., Nava, M., Castro, A. V., Angarita, L., Parra, H., Durán‐Agüero, S., Rojas-Gómez, D. M., Galbán, N., Áñez, R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063133 · Cited by 26 · see citing works

Aspirin modulates production of pro-inflammatory and pro-resolving mediators in endothelial cells

Rood, K. M., Patel, N., DeVengencie, I., Quinn, J. P., Gowdy, K. M., Costantine, M. M., & Kniss, D. A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0283163 · Cited by 25 · see citing works

The role of Resolvin D1 in liver diseases

Yang, M., Song, X.-Q., Han, M., & Liu, H. (2022) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2022.106634 · Cited by 24 · see citing works

Arachidonic Acid and Docosahexaenoic Acid Metabolites in the Airways of Adults With Cystic Fibrosis: Effect of Docosahexaenoic Acid Supplementation

Teopompi, E., Risé, P., Pisi, R., Buccellati, C., Aiello, M., Pisi, G., Tripodi, M. C., Fainardi, V., Clini, E. M., Chetta, A. A., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00938 · Cited by 24 · see citing works

Can Inflammation-Resolution Provide Clues to Treat Patients According to Their Plaque Phenotype?

Fredman, G. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00205 · Cited by 22 · see citing works

Specialized Pro-resolving Mediators Directs Cardiac Healing and Repair with Activation of Inflammation and Resolution Program in Heart Failure

Halade, G. V., & Tourki, B. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-21735-8_6 · Cited by 21 · see citing works

Can Specialized Pro-resolving Mediators Deliver Benefit Originally Expected from Fish Oil?

Rosenthal, M. D., Patel, J. J., Staton, K. M., Martindale, R. G., Moore, F. A., & Upchurch, G. R. (2018) · Current Gastroenterology Reports · doi:10.1007/s11894-018-0647-4 · Cited by 20 · see citing works

The Role of Serum Resolvin D1 Levels in Determining the Presence and Prognosis of ST-Segment Elevation Myocardial Infarction

Karayiğit, O., Nurkoç, S. G., Başyiğit, F., & Kızıltunç, E. (2022) · Medical Principles and Practice · doi:10.1159/000527064 · Cited by 19 · see citing works

Bioactive lipids as biomarkers of adverse reactions associated with apheresis platelet concentrate transfusion

Duchez, A., Fauteux‐Daniel, S., Sut, C., Ebermeyer, T., Heestermans, M., Arthaud, C., Eyraud, M., Prier, A., Audoux, E., Bertrand‐Michel, J., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1031968 · Cited by 18 · see citing works

Angiopoietin-like protein 3, an emerging cardiometabolic therapy target with systemic and cell-autonomous functions

Ruhanen, H., Haridas, P. A. N., Jauhiainen, M., & Olkkonen, V. M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158791 · Cited by 18 · see citing works

Specialized Pro‐Resolving Mediators as Emerging Players in Cardioprotection: From Inflammation Resolution to Therapeutic Potential

Bartolo, A. D., Romeo, N., Angelone, T., & Rocca, C. (2025) · Acta Physiologica · doi:10.1111/apha.70062 · Cited by 16 · see citing works

Pro-resolving lipid mediators in diseases: exploring the molecular basis and clinical implication

Li, C., Wang, Z., Yang, Y., Jiang, Q., Jiang, Y., Xiao, J., Shen, L., Wu, W., & Li, C. (2026) · Molecular Biomedicine · doi:10.1186/s43556-025-00400-5 · Cited by 19 · see citing works

ANGPTL3 deficiency alters the lipid profile and metabolism of cultured hepatocytes and human lipoproteins

Ruhanen, H., Haridas, P. A. N., Minicocci, I., Taskinen, J., Palmas, F., Costanzo, A. D., D’Erasmo, L., Metso, J., Partanen, J., Dalli, J., et al. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158679 · Cited by 16 · see citing works

Development and Validation of Methodologies for the Identification of Specialized Pro-Resolving Lipid Mediators and Classic Eicosanoids in Biological Matrices

Dooley, M., Saliani, A., & Dalli, J. (2024) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.4c00211 · Cited by 15 · see citing works

Pro-resolving lipid mediators in the resolution of neointimal hyperplasia pathogenesis in atherosclerotic diseases

Satish, M., & Agrawal, D. K. (2018) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2019.1563483 · Cited by 15 · see citing works

Receptors for pro-resolving mediators as a therapeutic tool for smooth muscle remodeling-associated disorders

Livshits, G., & Kalinkovich, A. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105340 · Cited by 15 · see citing works

DHA, RvD1, RvD5, and MaR1 reduce human coronary arteries contractions induced by PGE2

Bouhadoun, A., Manikpurage, H. D., Deschildre, C., Zalghout, S., Dubourdeau, M., Urbach, V., Ho‐Tin‐Noé, B., Deschamps, L., Michel, J., Longrois, D., et al. (2022) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2022.106700 · Cited by 13 · see citing works

Lipoxins and their relationship with inflammation-associated diseases. A systematic review

Serna-Orozco, M. F., Mosquera, M., & García‐Perdomo, H. A. (2023) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2023.06.001 · Cited by 13 · see citing works

Oral Resolvin D1 attenuates early inflammation but not intimal hyperplasia in a rat carotid angioplasty model

Mottola, G., Werlin, E. C., Wu, B., Chen, M., Chatterjee, A., Schaller, M. S., & Conte, M. S. (2019) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2019.106401 · Cited by 13 · see citing works

Integrated metabolomics, network pharmacology and biological verification to reveal the mechanisms of Nauclea officinalis treatment of LPS-induced acute lung injury

Han, X., Xu, S., Li, L., Wu, Y., Mai, S.-Y., Xie, Y., Tan, Y., Li, A., Xue, F., He, X., et al. (2022) · Chinese Medicine · doi:10.1186/s13020-022-00685-6 · Cited by 12 · see citing works

Dietary Technologies to Optimize Healing from Injury-Induced Inflammation

Sears, B., Perry, M., & Saha, A. K. (2020) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/1871523019666200512114210 · Cited by 12 · see citing works

COVID-19 and cancer: start the resolution!

Barksdale, C., Kipper, F. C., Tripathy, S., Subbian, S., Serhan, C. N., & Panigrahy, D. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10017-z · Cited by 13 · see citing works

Systemic Bioavailability and Dose Proportionality of Omega-3 Administered in Free Fatty Acid Form Compared With Ethyl Ester Form: Results of a Phase 1 Study in Healthy Volunteers

Offman, E. M., Davidson, M. H., Abu-Rashid, M., Chai, P., & Nilsson, C. A. M. (2017) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-016-0398-2 · Cited by 12 · see citing works

Pro-Resolving Inflammatory Effects of a Marine Oil Enriched in Specialized Pro-Resolving Mediators (SPMs) Supplement and Its Implication in Patients with Post-COVID Syndrome (PCS)

Aznar, A. G., Egea, F. M., Banzo, R. G., Gutiérrez, R., Rizo, J. M., Ledo, P. R., Nerín, I., & Regidor, P. (2024) · Biomedicines · doi:10.3390/biomedicines12102221 · Cited by 10 · see citing works

Resolvin D1 attenuates Ang II-induced hypertension in mice by inhibiting the proliferation, migration and phenotypic transformation of vascular smooth muscle cells by blocking the RhoA/mitogen-activated protein kinase pathway

Cheng, W., Zhang, J., Peng, S., Liu, J., Xu, Y. Q., Zhao, M., Xu, S., Pan, W. D., Yin, Z., Zheng, Z., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003610 · Cited by 10 · see citing works

Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis

Salazar, J. J., Pírela, D., Nava, M., Castro, A. V., Angarita, L., Parra, H., Durán‐Agüero, S., Rojas-Gómez, D. M., Galbán, N., Áñez, R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063133 · Cited by 26 · see citing works

Regression of human coronary artery plaque is associated with a high ratio of (18‐hydroxy‐eicosapentaenoic acid + resolvin E1) to leukotriene B 4

Welty, F. K., Schulte, F., Alfaddagh, A., Elajami, T. K., Bistrian, B. R., & Hardt, M. (2021) · The FASEB Journal · doi:10.1096/fj.202002471r · Cited by 57 · see citing works

Resolvins as proresolving inflammatory mediators in cardiovascular disease

Capó, X., Martorell, M., Busquets-Cortés, C., Tejada, S., Tur, J. A., Pons, A., & Sureda, A. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.07.018 · Cited by 42 · see citing works

Pro-resolution therapeutics for cardiovascular diseases

Heinz, J., Marinello, M., & Fredman, G. (2017) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2017.03.004 · Cited by 12 · see citing works

Specialized pro-resolving lipid mediators in cardiovascular disease, diagnosis, and therapy

Kim, A. S., & Conte, M. S. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.011 · Cited by 40 · see citing works